Associated Formulations Private Limited
About Associated Formulations Private Limited
Data last updated:
Associated Formulations Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC329571. Its GSTIN is 07AAQCA5247G1ZH (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajesh Kumar Pandey and Raghavendra Mohan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 41 Upper Ground Floor Block – C Pocket – 9 Sector – 8 Opp. Saroj Hospital, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.68 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹25.35 Lakh (net margin 2.9%) and EBITDA of ₹41.16 Lakh (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 28% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 41 Upper Ground Floor Block – C Pocket – 9 Sector – 8 Opp. Saroj Hospital, New Delhi, Delhi, India – 110085
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Associated Formulations Private Limited
The main business activity of Associated Formulations is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Associated Formulations Private Limited FY 2025 filings available
Associated Formulations Private Limited reported revenue of ₹8.68 Cr (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Associated Formulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 33% growth in the latest year. EBITDA rose 113% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Associated Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹41.16 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹25.35 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Associated Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Associated Formulations are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Associated Formulations Private Limited
Associated Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prabhu Interiors Pvt Ltd | ₹8.75 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Mumbai, Maharashtra, India |
| Aps Biotech Private Limited | ₹8.72 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Roorkee, Uttarakhand, India |
| Integra Life Sciences Private Limited | ₹8.72 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Priyadarshini Microtech Private Limited | ₹8.71 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Navi Mumbai, Maharashtra, India |
| Walter Healthcare Private Limited | ₹8.69 Cr (FY 2025) | •••• | •••• | 56.0% | •••• | Mohali, Punjab, India |
| Associated Formulations Private Limited this company | ₹8.68 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | New Delhi, Delhi, India |
| Atilus Pharma Private Limited | ₹8.68 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Mumbai, Maharashtra, India |
| Runicha Healthcare Private Limited | ₹8.66 Cr (FY 2025) | •••• | •••• | 6057.0% | •••• | Dhule, Maharashtra, India |
| Pehal Life Sciences Private Limited | ₹8.66 Cr (FY 2024) | •••• | •••• | -33.0% | •••• | Mumbai, Maharashtra, India |
| Waxsen Lifescience Private Limited | ₹8.64 Cr (FY 2019) | •••• | •••• | -50.0% | •••• | Mumbai, Maharashtra, India |
| Apogen Remedies Private Limited | ₹8.63 Cr (FY 2025) | •••• | •••• | -35.0% | •••• | Siddipet, Telangana, India |
Peers are the five companies nearest above and the five nearest below Associated Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Associated Formulations Private Limited
Associated Formulations Private Limited is audited by Agarwal Preeti & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Agarwal Preeti & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Associated Formulations Private Limited
Associated Formulations has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Pandey | Director | 30 Nov 2023 | 2 Years 10 Months | Current |
| Raghavendra Mohan Also directs: Aethicz Biolife LLP, Martyn Nikk Pharma Private Limited | Director | 25 Jun 2022 | 4 Years 3 Months | Current |
| Pranshul Aggarwal | Director | 17 Mar 2021 | 5 Years 6 Months | Current |
Ownership and Shareholding of Associated Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Associated Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2025 | Others | ₹2 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Associated Formulations Private Limited
Associated Formulations Private Limited has a workforce of 9 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Associated Formulations Private Limited
Associated Formulations Private Limited has 8 board changes on record since 2018: 3 appointments and 5 cessations. The latest: Rajesh Kumar Pandey was appointed as Director on 30 Nov 2023.
Credit Ratings, Litigation & Regulatory Alerts for Associated Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Associated Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Associated Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Associated Formulations Private Limited
Associated Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAQCA5247G1ZH | Delhi | Active | 21 Jun 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Associated Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Associated Formulations Private Limited
Associated Formulations is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 February 2018 (8+ years old) and is registered under CIN U74999DL2018PTC329571.
Associated Formulations reported revenue of ₹8.68 Cr for FY 2025 (up 33% YoY).
Associated Formulations has 3 current directors:
- Rajesh Kumar Pandey - Director
- Raghavendra Mohan - Director
- Pranshul Aggarwal - Director
Associated Formulations reported a net profit of ₹25.35 Lakh (net margin 2.9%) and EBITDA of ₹41.16 Lakh (EBITDA margin 4.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Associated Formulations is 5% over three years and 28% over five years. In the latest year (FY 2025) revenue rose 33%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Associated Formulations is 07AAQCA5247G1ZH, registered in Delhi.
The CIN (Corporate Identification Number) of Associated Formulations is U74999DL2018PTC329571. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Associated Formulations was incorporated on 17 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Associated Formulations by revenue are Prabhu Interiors Pvt Ltd, Aps Biotech Private Limited, Integra Life Sciences Private Limited, Priyadarshini Microtech Private Limited, Walter Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).
Rajesh Kumar Pandey was appointed as Director on 30 Nov 2023. Vijay Kumar Aggarwal ceased to be Director on 30 Nov 2023. Raghavendra Mohan ceased to be Additional Director on 30 Sep 2022. Associated Formulations has 8 board changes on record in total.
The registered office of Associated Formulations is at Plot No. 41 Upper Ground Floor Block – C Pocket – 9 Sector – 8 Opp. Saroj Hospital, New Delhi, Delhi, India – 110085.